Home > CPHI
Published on
Related News
Almirall and CRG collaborate to identify molecular pathways and biomarkers specific to atopic dermatitis.
Almirall, Barcelona Supercomputing Center (BSC) and Nostrum Biodiscovery collaborate to design new protein-protein modulators through Artificial Intelligence.
Related News
Published on 09/02/2024
Looking for new therapeutic approaches for AD
Almirall and CRG collaborate to identify molecular pathways and biomarkers specific to atopic dermatitis.
Published on 25/05/2023
New models for non-melanoma skin cancer
Almirall and the Centre for Genomic Regulation (CRG) collaborate to develop and characterize novel preclinical models for non-melanoma skin cancer
Published on 28/11/2022
Almirall joins IMI project FACILITATE
We participate in FACILITATE, a patient-driven Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants.
